Musculoskeletal Citations

 

Guselkumab vs Adalimumab in Plaque Psoriasis

July 22, 2015

Guselkumab, a selective antagonist of IL-23, went head to head with adalimumab in a year-long phase 2 trial of 293 patients with moderate to severe plaque psoriasis. A quick synopsis of the results here.

Osteoporosis Rx Update: Sequential and Combination Therapy

July 07, 2015

New study results shed light on questions about the effect of combining drugs to treat osteoporosis and what happens after a switch from one drug to another.

First-Line Rx in Pyoderma Gangrenosum

July 02, 2015

There is now clinical evidence to support cyclosporine and prednisolone as first line options in the treatment of pyoderma gangrenosum.